Medinet: (Progress of disclosure matters) Taiwanese regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)
Medinet: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses
Medinet: Summary of financial results for the 2nd quarter of 2024
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment
Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions
Medinet: Summary of Financial Results for the first quarter 2024
Medinet: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses
Medinet: Start contract manufacturing of new cell-processed products using our patented technology
Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment
Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions
Medinet: Signed a joint research agreement with Tokyo Medical and Dental University on novel immunotherapy for treatment-resistant viral infections after hematopoietic cell transplantation
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment
Medinet: Explanatory materials on business plans and growth potential
Medinet: A patent relating to “sugar chain modified T cells” was established in Japan
Medinet: (Progress of disclosure matters) Commencement of provision of cancer immune cell treatment using gamma-delta T cell culture processing technology in Taiwan
Medinet: Summary of Financial Results 2023
No Data